Cartesian Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FMR LLC | 05/12/2025 | 2.34 M | $30.84 M | -3.44% | 9.03% |
BIOIMPACT CAPITAL LLC | 05/15/2025 | 790.78 K | $10.42 M | 9.66% | 3.05% |
BLACKROCK, INC. | 05/02/2025 | 673.05 K | $8.87 M | 2.07% | 2.60% |
SIREN, L.L.C. | 05/23/2025 | 563.27 K | $7.42 M | -1.57% | 2.17% |
VANGUARD GROUP INC | 05/09/2025 | 503.54 K | $6.64 M | 17.24% | 1.94% |
05/14/2025 | 260.01 K | $3.43 M | 49.81% | 1.00% | |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 225.50 K | $2.97 M | 1.92% | 0.87% |
STATE STREET CORP | 05/15/2025 | 201.13 K | $2.65 M | 16.51% | 0.78% |
JPMORGAN CHASE & CO | 05/12/2025 | 195.04 K | $2.57 M | -29.01% | 0.75% |
683 CAPITAL MANAGEMENT, LLC | 05/15/2025 | 150.00 K | $1.98 M | 20.00% | 0.58% |
CITADEL ADVISORS LLC | 05/15/2025 | 147.30 K | $1.94 M | -53.24% | 0.57% |
NORTHERN TRUST CORP | 05/13/2025 | 92.34 K | $1.22 M | -2.83% | 0.36% |
MARSHALL WACE, LLP | 05/15/2025 | 38.61 K | $508.81 K | 100.00% | 0.15% |
UBS GROUP AG | 05/13/2025 | 31.12 K | $410.14 K | 77.01% | 0.12% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 05/09/2025 | 29.30 K | $386.21 K | 9.33% | 0.11% |
05/12/2025 | 27.87 K | $367.31 K | 100.00% | 0.11% | |
FREESTONE CAPITAL HOLDINGS, LLC | 05/13/2025 | 25.92 K | $341.64 K | 0.00% | 0.10% |
IKARIAN CAPITAL, LLC | 05/15/2025 | 22.17 K | $292.15 K | -57.51% | 0.09% |
DELPHI FINANCIAL GROUP, INC. | 05/12/2025 | 22.03 K | $290.33 K | 0.00% | 0.09% |
BANK OF NEW YORK MELLON CORP | 04/29/2025 | 20.94 K | $275.95 K | 7.88% | 0.08% |
ALPS ADVISORS INC | 04/30/2025 | 19.39 K | $255.59 K | -5.64% | 0.07% |
MORGAN STANLEY | 05/15/2025 | 17.85 K | $235.26 K | -26.43% | 0.07% |
GSA CAPITAL PARTNERS LLP | 05/08/2025 | 16.79 K | $221.00 K | 100.00% | 0.06% |
GOLDMAN SACHS GROUP INC | 05/16/2025 | 15.78 K | $207.92 K | -42.69% | 0.06% |
TWIN FOCUS CAPITAL PARTNERS, LLC | 05/13/2025 | 15.00 K | $197.70 K | 25.00% | 0.06% |
BARCLAYS PLC | 05/15/2025 | 14.37 K | $190.00 K | -24.77% | 0.06% |
RHUMBLINE ADVISERS | 05/29/2025 | 13.01 K | $171.41 K | 27.50% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 12.46 K | $164.22 K | 100.00% | 0.05% |
TWO SIGMA INVESTMENTS, LP | 05/15/2025 | 11.02 K | $145.18 K | -6.75% | 0.04% |
VIRTUS INVESTMENT ADVISERS, INC. | 05/15/2025 | 8.16 K | $107.55 K | 100.00% | 0.03% |
CITIGROUP INC | 05/12/2025 | 7.71 K | $101.59 K | -6.58% | 0.03% |
DEUTSCHE BANK AG\ | 05/09/2025 | 7.42 K | $97.85 K | 104.07% | 0.03% |
QUEST PARTNERS LLC | 05/14/2025 | 7.19 K | $94.78 K | 100.00% | 0.03% |
METLIFE INVESTMENT MANAGEMENT, LLC | 05/14/2025 | 6.67 K | $87.87 K | 0.00% | 0.03% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 05/15/2025 | 6.02 K | $79.34 K | 4.04% | 0.02% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 5.98 K | $78.83 K | -48.84% | 0.02% |
CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 04/30/2025 | 5.10 K | $67.19 K | -5.40% | 0.02% |
COREBRIDGE FINANCIAL, INC. | 05/14/2025 | 5.05 K | $66.52 K | -1.46% | 0.02% |
WELLS FARGO & COMPANY/MN | 05/13/2025 | 4.96 K | $65.31 K | 2.23% | 0.02% |
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 04/24/2025 | 4.59 K | $13.41 K | 0.64% | 0.02% |
NEW YORK STATE COMMON RETIREMENT FUND | 05/01/2025 | 3.90 K | $51.00 K | 0.00% | 0.02% |
05/09/2025 | 2.94 K | $38.74 K | 102.27% | 0.01% | |
ROYAL BANK OF CANADA | 05/15/2025 | 2.39 K | $31.00 K | -56.33% | 0.01% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 2.28 K | $30.06 K | 266.13% | 0.01% |
LEGAL & GENERAL GROUP PLC | 05/15/2025 | 1.15 K | $15.16 K | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 1.02 K | $13.42 K | -38.12% | 0.00% |
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | 05/15/2025 | 766 | $10.10 K | 0.00% | 0.00% |
ZURCHER KANTONALBANK (ZURICH CANTONALBANK) | 05/07/2025 | 712 | $9.38 K | 100.00% | 0.00% |
AMERITAS INVESTMENT PARTNERS, INC. | 05/12/2025 | 708 | $9.33 K | 0.00% | 0.00% |
04/29/2025 | 650 | $8.57 K | 21.72% | 0.00% |
Cartesian Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 73 institutional investors and hedge funds held shares of Cartesian Therapeutics, Inc.. The most heavily invested institutionals were:
FMR LLC: 2.34 M
BioImpact Capital LLC: 790,779
BlackRock, Inc.: 673,050
Siren, L.L.C.: 563,272
VANGUARD GROUP INC: 503,537
GEODE CAPITAL MANAGEMENT, LLC: 225,500
25.41% of Cartesian Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 6.77 M shares in the last 24 months. This purchase volume represents approximately $77.86 M in transactions.